The Food and Drug Administration on Friday ousted its top spokesperson, Emily Miller, after less than two weeks on the job, the New York Times reports.
Miller’s removal comes amid controversy surrounding its emergency use authorization of convalescent blood plasma as a coronavirus treatment.
Save to Favorites